Showing results (601-610 of 687) with videos related to
Sort By:
Pageof 69
Pharmacological Research|April 2, 2013
Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participantsMarcin Barylski, Shekoufeh Nikfar, Dimitri P Mikhailidis, et al.Current Medical Research and Opinion|February 23, 2013
Effects of statins on lipid profile in chronic kidney disease patients: a meta-analysis of randomized controlled trialsDragana Nikolic, Shekoufeh Nikfar, Pooneh Salari, et al.Expert Opinion on Therapeutic Targets|September 11, 2008
Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?Konstantina Toli, Kosmas I Paraskevas, Maria V Poulakou, et al.Angiology|April 7, 2011
Peroxisome proliferator-activated receptors and atherosclerosisSanja S Soskić, Branislava D Dobutović, Emina M Sudar, et al.International Journal of Cardiology|April 18, 2015
Lack of efficacy of resveratrol on C-reactive protein and selected cardiovascular risk factors--Results from a systematic review and meta-analysis of randomized controlled trialsAmirhossein Sahebkar, Corina Serban, Sorin Ursoniu, et al.Archives of Medical Science : AMS|August 10, 2023
The role of nutraceuticals in heart failure muscle wasting as a result of inflammatory activity. The International Lipid Expert Panel (ILEP) Position PaperAgata Bielecka-Dabrowa, Maciej Banach, Andrzej Wittczak, et al.Angiology|November 27, 2009
Cardiac adaptive responses after hypoxia in an experimental modelIsmaeel Bin-Jaliah, Hania I Ammar, Dimitri P Mikhailidis, et al.Nutrition Research Reviews|March 17, 2020
Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP)Arrigo F G Cicero, Alessandro Colletti, Stephan von Haehling, et al.Pharmacological Research|February 23, 2020
Statin therapy in athletes and patients performing regular intense exercise - Position paper from the International Lipid Expert Panel (ILEP)Niki Katsiki, Dimitri P Mikhailidis, Gani Bajraktari, et al.Liver International : Official Journal of the International Association for the Study of the Liver|April 5, 2011
Serum ferritin is a discriminant marker for both fibrosis and inflammation in histologically proven non-alcoholic fatty liver disease patientsPinelopi Manousou, George Kalambokis, Federica Grillo, et al.Pageof 69